Vaxcyte, Inc. (PCVX)
58.52
-0.88
(-1.48%)
USD |
NASDAQ |
Nov 18, 16:00
58.56
+0.04
(+0.08%)
After-Hours: 20:00
Vaxcyte EPS Diluted (Quarterly) : -1.995 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.995 |
| June 30, 2026 | -1.968 |
| March 31, 2026 | -2.298 |
| December 31, 2025 | -1.881 |
| September 30, 2025 | -1.563 |
| June 30, 2025 | -1.224 |
| March 31, 2025 | -1.037 |
| December 31, 2024 | -1.098 |
| September 30, 2024 | -0.8337 |
| June 30, 2024 | -1.098 |
| March 31, 2024 | -0.8507 |
| December 31, 2023 | -1.896 |
| September 30, 2023 | -0.9114 |
| June 30, 2023 | -0.6969 |
| March 31, 2023 | -0.7014 |
| December 31, 2022 | -1.028 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9343 |
| June 30, 2022 | -0.798 |
| March 31, 2022 | -0.6774 |
| December 31, 2021 | -0.5422 |
| September 30, 2021 | -0.51 |
| June 30, 2021 | -0.4597 |
| March 31, 2021 | -0.4147 |
| December 31, 2020 | -0.406 |
| September 30, 2020 | -0.4125 |
| June 30, 2020 | -0.3994 |
| March 31, 2020 | -0.5555 |
| December 31, 2019 | -0.2993 |
| September 30, 2019 | -0.2316 |
| June 30, 2019 | -0.2102 |
| March 31, 2019 | -0.2798 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | 0.3791 |
| Vir Biotechnology, Inc. | -0.5686 |
| Anavex Life Sciences Corp. | 0.0842 |
| Revolution Medicines, Inc. | -1.896 |
| Foghorn Therapeutics, Inc. | 0.8011 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -297.06M |
| Total Expenses (Quarterly) | 297.06M |
| Enterprise Value | 7.667B |
| Earnings Yield | -13.91% |
| Normalized Earnings Yield | -13.91 |